All In Biotech

Drug Trial Radar · NCT00112021

A Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

A Phase 2B, Randomized, Double-Blinded, Placebo-Controlled, Dose Ranging, Multicenter Study to Examine the Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects

Last checked: Nov 20, 2026Latest source record: Apr 10, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

400

Actual

Start

May 2005

Primary completion

Nov 2005

Study completion Nov 2005

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
May 30, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study to examine the effect of pramlintide on body weight and its safety and tolerability in obese subjects.

Conditions

  • Obesity

Interventions

  • pramlintide acetateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To examine the effect of pramlintide on body weight in obese subjectsTime frame: Approximately 16 weeks
  2. To examine the safety and tolerability of pramlintide in obese subjectsTime frame: Approximately 16 weeks

Locations

21 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Chula Vista, California

  • Research Site

    San Diego, California

  • Research Site

    Walnut Creek, California

  • Research Site

    Miami, Florida

  • Research Site

    Augusta, Georgia

  • Research Site

    Chicago, Illinois

  • Research Site

    Indianapolis, Indiana

  • Research Site

    Overland Park, Kansas

  • Research Site

    Baton Rouge, Louisiana

  • Research Site

    Detroit, Michigan

  • Research Site

    Edina, Minnesota

  • Research Site

    St Louis, Missouri

  • Research Site

    Butte, Montana

  • Research Site

    New York, New York

  • Research Site

    Cincinnati, Ohio

  • Research Site

    Portland, Oregon

  • Research Site

    Philadelphia, Pennsylvania

  • Research Site

    Austin, Texas

  • Research Site

    San Antonio, Texas

  • Research Site

    Salt Lake City, Utah

  • Research Site

    Olympia, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.